Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3789
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

FGFR1 Cooperates With EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Combined Blockade of VEGFR-2 and VEGFR-3 Inhibits Inflammatory Lymphangiogenesis in Early and Middle Stages

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Chemoenzymatic Approach Toward the Synthesis of 3-O-(Α/Β)-Glucosylated 3-Hydroxy-Β-Lactams

ACS Omega
ChemistryChemical Engineering
2018English

Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

Screening and Preventive Strategies in Esophagogastric Cancer

Surgical Oncology Clinics of North America
SurgeryOncology
2017English

Phosphoinositide 3-Kinase-Β (PI3Kβ); PI3Kδ

Science-Business eXchange
2011English

Core-Level Photoelectron Spectroscopy Study of the Au/Si(111)5×2,α−3×3,β−3×3,and6×6surfaces

Physical Review B
2001English

Combined BRAFV600E and MEK Blockade for BRAFV600E-mutant Gliomas

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2016English

Β-Naag Rescues LTP From Blockade by NAAG in Rat Dentate Gyrus via the Type 3 Metabotropic Glutamate Receptor

Journal of Neurophysiology
NeurosciencePhysiology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy